Save $700 off your ticket!
Register before March 6, 2026, to save $700 off the ChinaBio™ Partnering Forum portion of your ticket.
China's clinical edge: Your strategic roadmap
From protocol strategy and late-stage delivery, to recruitment, data quality and AI enabled operations, discover how to successfully design, execute and scale clinical trials in China today.
Master strategic trial design: From regulatory alignment to global scalability
Gain competitive advantage by designing China-ready protocols that seamlessly meet NMPA expectations while accelerating global development timelines. Learn how regulatory evolution and protocol decisions interconnect to affect feasibility, timelines, and worldwide pathway success.
Execute complex programs at scale: Late-Stage excellence and patient engagement
Access China’s large patient population and gain practical approaches to translate patient access into consistent recruitment and retention across diverse sites and regions.
Navigate critical partnership decisions: CRO selection and data excellence
Master the strategic choices around Chinese vs global CROs while establishing operational practices that deliver global-ready data. Learn governance frameworks that ensure quality, speed, and regulatory confidence while building inspection readiness from day one.
Harness technology for competitive advantage: AI-Powered clinical operations
Explore cutting-edge AI applications in data analysis, monitoring, and trial operations that deliver shortened development timelines and improved probability of success through optimized design and adaptive strategies.
Define the future standard: China-to-global clinical excellence
Unlock actionable insights on how China-origin trials can best support global development pathways, understand what capabilities will define excellence by 2027, and position your programs as the foundation for worldwide regulatory success.
Who should attend?
Whether you're a China based sponsor or one evaluating China opportunities, a CRO expanding operations, or a service provider supporting global programs, you'll find practical insights from peers who are actively delivering trials in this market.
This event is particularly valuable if you're a senior leader, director, or manager responsible for:
• Making strategic decisions about where and how to run trials
• Designing protocols that work across markets
• Ensuring regulatory compliance and data quality
• Managing clinical operations and timelines
• Selecting and managing CROs and vendors
• Evaluating new technologies and AI solutions
• Overseeing procurement and supply chain
• Building capabilities in China or APAC
Key roles include:
Clinical Operations • Clinical Trial Management • Clinical Project Management • Clinical Regulatory Affairs • Clinical Investigation • Clinical Research • Clinical Data Management • Clinical Research • Clinical Medical Affairs • Global Clinical Strategy • China or APAC Clinical Trials • Biostatistics • Clinical Quality Assurance • Clinical Technology / AI • Clinical Oversight • Clinical Procurement • Clinical Sourcing/Outsourcing • Clinical Supply Chain • Vendor Management
Clinical Trials Highlights
Experience the thrill of Clinical Trials live and in person during ChinaBio™ Partnering Forum! Connect with over 1,000 attendees in the welcoming atmosphere of the Kerry Hotel Pudong, located in the heart of Shanghai, China.
FAQs
What is Clinical Trials at ChinaBio?
Clinical Trials at ChinaBio is a specialized one-day forum focused on the practical delivery of clinical trials in China's rapidly maturing pharmaceutical market. Part of this year's ChinaBio™ Partnering Forum, this conference is curated for senior clinical leaders, operators and industry partners looking to advance their global strategy. The forum addresses the critical shift in China's clinical trials landscape, where delivery quality now defines success as trials move deeper into Phase II/III studies and broader global development pathways. Attendees explore how clinical trials are being designed, executed, and scaled in China today, covering:
What Makes It Unique: Clinical Trials at ChinaBio provides experience-led perspectives from industry experts successfully delivering speed, quality, and global confidence in China's evolving clinical landscape. Through panel discussions, fireside chats, and extensive networking opportunities, biopharma professionals will gain actionable strategies to leverage China's advantages in worldwide drug development programs.
Co-located with ChinaBio™ Partnering Forum, attendees can choose to upgrade their ticket for additional partnering opportunities, one-to-one meetings with 500+ unique companies, and networking with international stakeholders across 30 countries - securing both events at a reduced-rate for maximum value and partnership potential.
When and where is Clinical Trials at ChinaBio taking place?
The Clinical Trials at ChinaBio conference will take place on April 27th, 2026, in Shanghai, China at the venue Kerry Hotel Pudong, Shanghai. You can find out more venue information on the Plan Your Visit page.
What topics will be covered at the event?
The Clinical Trials at ChinaBio conference covers a comprehensive range of topics including:
- Protocol strategy and NMPA regulatory alignment
- Late-stage clinical development and complex program delivery
- Patient recruitment and retention optimization
- Data quality standards for global submissions
- AI-enabled clinical operations and technology integration
- Strategic CRO selection and partnership models
What is the format of the Clinical Trials at ChinaBio event?
The Clinical Trials at ChinaBio event is a one-day in-person conference taking place on April 27th, 2026, concluding with the ChinaBio™ Partnering Forum welcome reception, a shared evening networking reception bringing together the attendees across four co-located events:
- Clinical Trials at ChinaBio (April 27th)
- ChinaBio™ Partnering Forum (April 28–29, 2026)
- Cell & Gene Therapy Summit at ChinaBio (April 28–29, 2026)
- Antibody & ADC Summit at ChinaBio (April 28–29, 2026)
Will there be opportunities for networking?
Yes, the event is designed to bring together all key stakeholders involved in clinical trials, including sponsors (pharmaceutical/biotech companies), investigators, patients, regulatory agencies, contract research organizations (CROs) and solution providers from around the globe, providing an excellent opportunity for networking.
The agenda includes interactive panel discussions specifically designed for raising questions, and engaging fireside chats to open up the conversation and stimulate invaluable peer-discussion during networking breaks, helping you connect with like-minded professionals.
Add-on one of the co-located events for full access to extensive Partnering across ChinaBio™ Partnering Forum for a combined event ticket at a reduced price:
- ChinaBio™ Partnering Forum (April 28–29, 2026)
- Cell & Gene Therapy Summit at ChinaBio (April 28–29, 2026)
- Antibody & ADC Summit at ChinaBio (April 28–29, 2026)
Who organizes the Clinical Trials at ChinaBio event?
The congress is organized by Informa Connect, part of Informa PLC. View more of our biotech and pharma events here.
Where can I find the detailed agenda?
The detailed agenda is available to view here.